The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands

Journal of Experimental Medicine

Volumn 185, Issue 2, 1997, Pages 219-229

  Madrenas, Joaquín ^a,b   Chau, Luan A ^a   Smith, Judy ^c   Bluestone, Jeffrey A ^c   Germain, Ronald N ^d  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF CHICAGO   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CELLULAR DISTRIBUTION; IMMUNOLOGICAL TOLERANCE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 0031048822     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.2.219     Document Type: Article

References (76)

1. Sloan-Lancaster, J., A.S. Shaw, J.B. Rothbard, and P.M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of ZAP-70 recruitment in APL-incluced T cell anergy. Cell. 79:913-922.
2. Madrenas, J., R.L. Wange, J.L. Wang, N.A. Isakov, L.E. Samelson, and R.N. Germain. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science (Wash. DC). 267:515-518.
3. Kersh, G.J., and P.M. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature (Lond.). 380:495-498.
4. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (Wash. DC). 252:1308-1310.
5. De Magistris, M., J. Alexander, M. Coggeshall, A. Altman, F.C. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 68:625-634.
6. Windhagen, A., C. Scholz, P. Hollsberg, H. Fukaura, A. Sette, and D.A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity. 2:373-380.
7. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling J. Exp. Med. 177:1047-1060.
8. Sloan-Lancaster, J., B.D. Evavold, and P.M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (Lond.). 363:156-159.
9. Ruppert, J., J. Alexander, K. Snoke, M. Coggeshall, E. Herbert, D. McKenzie, H.M. Grey, and A. Sette. 1993. Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc. Natl. Acad. Sci. USA. 90:2671-2675.
10. Madrenas, J., R.H. Schwartz, and R.N. Germain. 1996. IL-2 and not TCR signaling patterns control anergy induction by agonists or partial agonists. Proc. Natl. Acad. Sci. USA. In press.
11. Evavold, B.D., J. Sloan-Lancaster, and P.M. Allen. 1993. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today. 14:602-609.
12. Madrenas, J., and R.N. Germain. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T cell activation. Semin. Immunol. 8: 83-101.
13. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
14. McKeithan, T.W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92: 5042-5046.
15. McConnell, H.M., H.G. Wada, S. Arimilli, K.S. Fok, and B. Nag. 1995. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA. 92:2750-2754.
16. + T cells in response to antagonist ligands. J. Exp. Med. 184:149-157.
17. Alam, S.M., P.J. Travers, J.L. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R.J. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature (Lond.). 381: 616-620.
18. Lyons, D.S., S.A. Lieberman, J. Hampl, J.J. Boniface, Y. Chien, L.J. Berg, and M.M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:51-59.
19. Yoon, S.T., U. Dianzani, K. Bottomly, and C.A. Janeway, Jr. 1994. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity. 1:563-569.
20. Janeway, C.A., Jr. 1995. Ligands for the T-cell receptor: hard times for avidity models. Immunol. Today. 16:223-225.
21. Ehrich, E.W., B. Devaux, E.P. Rock, J.L Jorgensen, M.M. Davis, and Y.-h. Chien. 1993. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen. J. Exp. Med. 178:713-722.
22. Janeway, C.A., Jr. 1992. T cell receptor signaling: high fives or hand clasps? Curr. Biol. 2:591-593.
23. Janeway, C.A., Jr., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76:275-285.
24. lck. Nature (Lond.). 338:257-259.
25. lck. Nature (Lond.). 350:62-66.
26. Dianzani, U., A. Shaw, B.K. al-Ramadi, R.T. Kubo, and C.J. Janeway, Jr. 1992. Physical association of CD4 with the T cell receptor. J. Immunol. 148:678-688.
27. lck. Mol. Cell. Biol. 12:2720-2729.
28. Luescher, I.F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (Lond.). 373:353-356.
29. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1994. Specificity and flexibility in thymic selection. Nature (Lond.). 369: 750-752.
30. Mannie, M.D., J.M. Rosser, and G.A. White. 1995. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J. Immunol. 154:2642-2654.
31. Vidal, K., B.L. Hsu, C.B. Williams, and P.M. Allen. 1996. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183:1311-1321.
32. Sloan-Lancaster, J., and P.M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27.
33. Matis, L.A., D.L. Longo, S.M. Hedrick, C. Hannum, E. Margoliash, and R.H. Schwartz. 1983. Clonal analysis of the major histocompatibility complex restriction and the fine specificity of antigen recognition in the T cell proliferative response to cytochrome C. J. Immunol. 130:1527-1535.
34. Berkower, I., H. Kawamura, L.A. Matis, and J.A. Berzofsky. 1985. T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance. J. Immunol. 135:2628-2634.
35. Ronchese, F., R.H. Schwartz, and R.N. Germain. 1987. Functionally distinct subsites on a class II major histocompatibility complex molecule. Nature (Lond.). 329:254-256.
36. König, R., X. Shen, and R.N. Germain. 1995. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779-787.
37. Dialynas, D.P., Z.S. Quan, K.A. Wall, A. Pierres, J. Quintans, M.R. Loken, M. Pierres, and F.W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131: 2445-2451.
38. Ozato, K., N. Mayer, and D.H. Sachs. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533-540.
39. Havran, W.L., M. Poenie, J. Kimura, R. Tsien, A. Weiss, and J.P. Allison. 1987. Expression and function of the CD3-antigen receptor on murine CD4+8+ thymocytes. Nature (Lond.). 330:170-173.
40. Kostelny, S.A., M.S. Cole, and J.Y. Tso. 1992. Formation of a bispecific antibody by the use of leucine zippers. J. Immunol. 148:1547-1553.
41. Janeway, C.A., Jr. 1992. The T cell receptor as a multicomponent signaling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645-674.
42. König, R., L.Y. Huang, and R.N. Germain. 1992. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature (Lond.). 356: 796-798.
43. Cammarota, G., A. Scheirle, B. Takacs, D.M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature (Lond.). 356:799-801.
44. Tsitoura, D.C., W. Holter, A. Cerwenka, C.M. Gelder, and J.R. Lamb. 1996. Induction of anergy in human Th0 cells by stimulation with altered T cell antigen receptor ligands. J. Immunol. 156:2801-2808.
45. Alters, S.E., H.K. Song, and C.G. Fathman. 1993. Evidence that clonal anergy is induced in thymic migrant cells after anti-CD4-mediated transplantation tolerance. Transplantation. 56:633-638.
46. Waldmann, H., and S. Cobbold. 1993. The use of monoclonal antibodies to achieve immunological tolerance. Immunol. Today. 14:247-251.
47. Vignali, D.A., and J.L. Strominger. 1994. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179:1945-1956.
48. Rabinowitz, J.D., C. Beeson, C. Wülfing, K. Tate, P.M. Allen, M.M. Davis, and H.M. McConnell. 1996. Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity. 5:125-135.
49. Doyle, C., and J.L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature (Lond.). 330:256-259.
50. Norment, A.M., R.D. Salter, P. Parham, V.H. Engelhard, and D.R. Littman. 1988. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature (Lond.). 336:79-81.
51. Saizawa, K., J. Rojo, and C.A. Janeway, Jr. 1987. Evidence for a physical association of CD4 and the CD3:α:β T-cell receptor. Nature (Lond.). 328:260-263.
52. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:203-212.
53. Tite, J.P., A. Sloan, and C.A. Janeway, Jr. 1986. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal. J. Mol. Cell. Immunol. 2:179-190.
54. Saizawa, K., S. Haque, B. Jones, J. Rojo, J.P. Tite, J. Kaye, and C.A. Janeway, Jr. 1987. The L3T4 molecule is part of the helper T-cell antigen/Ia recognition complex. Ann. Inst. Pasteur Immunol. 138:138-143.
55. McCluskey, J., A. Singer, R.N. Germain, and D.H. Margulies. 1987. The role of CD4/L3T4 in T-lymphocyte function. Ann. Inst. Pasteur Immunol. 138:150-157.
56. Janeway, C.A., Jr., S. Haque, L.A. Smith, and K. Saizawa. 1987. The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies. J. Mol. Cell. Immunol. 3:121-131.
57. Anderson, P., M.L. Blue, and S.F. Schlossman. 1988. Co-modulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytes. J. Immunol. 140:1732-1737.
58. Eichmann, K., J.I. Jonsson, I. Falk, and F. Emmrich. 1987. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur. J. Immunol. 17:643-650.
59. lck. Cell. 55:301-308.
60. Janeway, C.A., Jr. 1988. T-cell development. Accessories or coreceptors? Nature (Lond.). 335:208-210.
61. Janeway, C.A., Jr. 1991. The co-receptor function of CD4. Semin. Immunol. 3:153-160.
62. König, R., S. Fleury, and R.N. Germain. 1996. The structural basis of CD4-MHC class II interactions: coreceptor contributions to T cell receptor antigen recognition and oligomerization-dependent signal transduction. Curr. Topics Microbiol. Immunol. 205:19-46.
63. Robey, E.A., F. Ramsdell, D. Kioussis, W. Sha, D. Loh, R. Axel, and B.J. Fowlkes. 1992. The level of CD8 expression can determine the outcome of thymic selection. Cell. 69: 1089-1096.
64. Sakihama, T., A. Smolyar, and E.L. Reinherz. 1995. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120. Proc. Natl. Acad. Sci. USA. 92:6444-6448.
65. Sakihama, T., A. Smolyar, and E.L. Reinherz. 1995. Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. Immunol. Today. 16:581-587.
66. Hogquist, K.A., S.C. Jameson, and M.J. Bevan. 1994. The ligand for positive selection of T lymphocytes in the thymus. Curr. Opin. Immunol. 6:273-278.
67. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27.
68. Ashton-Rickardt, P.G., A. Bandeira, J.R. Delaney, L. Van Kaer, H.P. Pircher, R.M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 76:651-663.
69. Sebzda, E., V.A. Wallace, J. Mayer, R.S. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations ot a single peptide. Science (Wash. DC). 263:1615-1618.
70. Rothenberg, E. 1995. Developmental biology of lymphocytes. The Immunologist. 3:172-175.
71. Alters, S.E., J.A. Shizuru, J. Ackerman, D. Grossman, K.B. Seydel, and C.G. Fathman. 1991. Anti-GD4 mediates clonal anergy during transplantation tolerance induction. J. Exp. Med. 173:491-494.
72. Pearson, T.C., J.C. Madsen, C.P. Larsen, P.J. Morris, and K.J. Wood. 1992. Induction of transplantation tolerance in adults using donor antigen and anti-GD4 monoclonal antibody. Transplantation. 54:475-183.
73. Shizuru, J.A., S.E. Alters, and C.G. Fathman. 1992. Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Immunol. Rev. 129:105-130.
74. Qin, S., S.P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" transplantation tolerance. Science (Wash. DC). 259:974-977.
75. Darby, C.R., A. Bushell, P.J. Morris, and K.J. Wood. 1994. Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade. Transplantation. 57:1419-1426.
76. Scully, R., S. Qin, S. Cobbold, and H. Waldmann. 1994. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells. Eur. J. Immunol. 24:2383-2392.